Comparison

Recombinant HSV-1 Glycoprotein D Protein

Item no. 230-30216-500
Manufacturer Raybiotech
Amount 500 ug
Category
Type Proteins Recombinant
Format Lyophilized powder
Applications WB, IP, ELISA, Dot
Specific against Human
Conjugate/Tag His
Purity >95% - SDS-PAGE under reducing conditions and visualized by Coomassie blue staining
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Available
Application Information
Functional Assay, Protein-protein Interaction, Post-translational Modifications, ELISA, EIA, Western Blotting, Dot Blotting, Immunoprecipitation, Protein Array, etc.
Storage/Stability
Upon arrival, the lyophilized protein may be stored for 2 weeks at 4°C. For long term storage, it is recommended to store desiccated below -20 °C in a manual defrost freezer. Following reconstitution, the protein may be stored for 2 weeks under sterile conditions at -20 °C.  For long term storage, it is recommended to make appropriate aliquots and store at -80 °C. Avoid repeated freeze-thaw cycles.
Formulation
Lyophilized from a 0.2 um filtered solution in PBS (pH 7.4)
Expressed Region
Lys26-Asn339
Expression System
Human embryonic kidney 293 (HEK293) cells
Purification
His-tag affinity purification by immobilized metal ion affinity chromatography (IMAC)
Concentration (lot specific)
Determined by BCA protein assay
Reconstitution
Briefly spin the vial and bring the contents to the bottom prior to opening. It is recommended to reconstitute at 0.5 - 1.0 mg/mL with sterile deionized water.
Endotoxin Level
<0.5 EU per ug of the protein as determined by the LAL method
Conjugation/Tag Notes
C-terminal His-tag
Molecular Weight (kDa)
Recombinant protein product has a calculated molecular mass of 35 kDa. Due to the abundant glycosylation, it migrates as approximately 45 kDa major protein band in SDS-PAGE under DTT, beta-mercaptoethanol reducing conditions. See deglycosylation analysis image below.
SDS-PAGE Image
Figure 1. Deglycosylation analysis of purified recombinant proteins. The same amount of purified proteins were untreated (Lane 2) or treated with protein deglycosylation enzymes under native (Lane 3) or reducing (Lane 4) conditions. Deglycosylation treatment resulted in a mobility shift of the protein to produce one reduced band at the expected size, thus indicating that the untreated recombinant protein (Lane 2) was glycosylated. Lane 1: protein standard ladder (kDa).Lane 2: untreated protein.Lane 3: treated protein with deglycosylation enzymes under native conditions.Lane 4: treated protein with deglycosylation enzymes under denature conditions.
Shipping
Ice packs

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 ug
Available: In stock
available

Delivery expected until 9/13/2024 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close